Margo Monroe is Senior Associate at Choate, Hall & Stewart LLP. Margo counsels start-ups, private and public companies, venture capitals, and world-class academic research institutions in a wide range of technologies at the intersection of life sciences and engineering, with an emphasis on engineered cell or gene-editing based therapies, diagnostics, and targeted delivery technologies.
Margo helps clients quickly understand, evaluate, and respond to patent issues that arise in the context of business deals and/or during R&D of new products and technologies, while also securing strong worldwide patent protection for assets, including those whose major uses provide unique business opportunities. Margo has advised clients through various phases of due diligence, including mergers and acquisitions, partnerships, fundraising, and IPOs, many of which have required strategic navigation of complex technical landscapes and emerging legal issues. Margo also counsels clients with respect to third party risks, IP landscape issues, and freedom-to-operate analyses to assist with R&D and/or business decisions. Her clients appreciate her ability to distill complex data into understandable and actionable formats.
Check back soon for more articles by Margo Monroe